BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2010
View Archived Issues
Scientists design PIE-12-trimer that specifically inhibits HIV entry into host cells
Read More
Phase I data presented on hypnotic agent GF-015535-00
Read More
Interim phase I/II data suggest safety of everolimus in advanced HCC
Read More
Novartis reports on clinical development of LDE-225
Read More
BI-10773 improves glycemic control in large study in type 2 diabetes
Read More
Phico Therapeutics details phase I tolerability of PT1.2
Read More
Immatics raises funds to advance cancer vaccine portfolio
Read More
NasVax begins phase IIa trial of oral anti-CD3 immunotherapy
Read More
University of Kansas claims new HSP 90 inhibitors
Read More
Pro-Pharmaceuticals and Numoda collaborate on phase III Davanat trial
Read More
FDA and EMA to review vandetanib for advanced medullary thyroid cancer
Read More
AnGes receives fast track status for Collategene in critical limb ischemia
Read More
Santaris Pharma to initiate phase IIa trial of miravirsen in hepatitis C
Read More
Dynavax begins phase Ib study of its universal flu vaccine candidate
Read More
GSK to use biomarker from OncoMethylome in immunotherapy program
Read More
S*BIO obtains funding to support clinical programs
Read More
DiagnoCure files PMA application with FDA for Progensa PCA3 assay
Read More
RXi and EyeGate Pharma collaborate on ocular drug delivery system
Read More
Abbott and Reata to codevelop bardoxolone methyl for CKD
Read More
New dual GLP-1/glucagon receptor agonists described
Read More
FDA orphan drug status for darinaparsin in peripheral T-cell lymphoma
Read More
Vifor and Kissei Pharma partner to develop and market PA-21 in Japan
Read More
European orphan status granted to rFVIIIFc in hemophilia A
Read More
OP Bio Factory and Nagoya University disclose new beta-NGF enhancers
Read More